Stay updated on Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T05:59:36.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:56:49.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial on recurrent glioblastoma, while a new version number has been added.
    Difference
    7%
    Check dated 2025-04-16T02:11:09.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page has been updated to reflect new dates and timeframes related to randomization and tumor progression, with the removal of outdated dates and timeframes.
    Difference
    1%
    Check dated 2025-04-08T23:46:53.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T18:41:33.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1.0%
    Check dated 2025-03-03T22:21:49.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial page.